All inquiries route through a single editorial inbox. Use the subject lines below to help us prioritize and route your message.
If you've found an error on the site — outdated pricing, an incorrect regulatory claim, a mischaracterized program — please email us at glpagonists@gmail.com with the subject line Correction request. Include the page URL, the specific claim in question, and a source supporting the correct information. We commit to evaluating every correction received and updating the site within 7 business days when warranted.
If you operate or represent a telehealth GLP-1 program and would like to submit current pricing, request a review, or correct information about your program, please email glpagonists@gmail.com with subject Provider inquiry. We evaluate every program against our published methodology; advertising relationships do not influence rankings or scoring.
For press inquiries — including interview requests, quote requests, or research collaboration — please email glpagonists@gmail.com with subject Press. Include your publication or organization, the topic, and your deadline.
For affiliate partnership and advertising inquiries, email glpagonists@gmail.com with subject Partnership. Note that all advertising relationships are governed by our affiliate disclosure and do not influence editorial rankings.
Your experience as a reader and as a patient is genuinely valuable to our editorial process. If you've used a telehealth GLP-1 provider and want to share what worked or didn't, send a short note to glpagonists@gmail.com with subject Reader feedback. We don't publish reader stories without explicit permission, and we never share contact information.
We are an editorial publication, not a medical provider. We can't answer questions about whether a specific medication is right for you, dose adjustments, side effects you're experiencing, or treatment decisions. For those questions, please consult your physician or the prescribing provider's clinical team.